Cargando…
Epigenetic regulation of osteopontin splicing isoform c defines its role as a microenvironmental factor to promote the survival of colon cancer cells from 5-FU treatment
BACKGROUND: Drug resistance to 5-fluorouracil (5-FU) and recurrence after chemotherapy in colorectal cancer remain a challenge to be resolved for the improvement of patient outcomes. It is recognized that a variety of secretory proteins released from the tumor cells exposed to chemo-drugs into the t...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491101/ https://www.ncbi.nlm.nih.gov/pubmed/32944000 http://dx.doi.org/10.1186/s12935-020-01541-z |
_version_ | 1783582152206581760 |
---|---|
author | Chang, Siyuan Huang, Jing Niu, Huan Wang, Jing Si, Yang Bai, Zhigang Cheng, Shan Ding, Wei |
author_facet | Chang, Siyuan Huang, Jing Niu, Huan Wang, Jing Si, Yang Bai, Zhigang Cheng, Shan Ding, Wei |
author_sort | Chang, Siyuan |
collection | PubMed |
description | BACKGROUND: Drug resistance to 5-fluorouracil (5-FU) and recurrence after chemotherapy in colorectal cancer remain a challenge to be resolved for the improvement of patient outcomes. It is recognized that a variety of secretory proteins released from the tumor cells exposed to chemo-drugs into the tumor microenvironment (TME) contributed to the cell-to-cell communication, and altered the drug sensitivity. One of these important factors is osteopontin (OPN), which exists in several functional forms from alternative splicing and post-translational processing. In colon cancer cells, increased total OPN expression was observed during the progression of tumors, however, the exact role and regulation of the OPN splicing isoforms was not well understood. METHODS: We assayed precisely the abundance of major OPN splicing isoforms under 5-FU treatments in colon cancer cell lines with different sensitivities to 5-FU, and also evaluated the effects of the condition medium from OPN splicing isoforms overexpressed cells on cell functions. The methods of nuclear calcium reporter assays and ChIP (chromatin immunoprecipitation) assays were used to investigate the molecular mechanism underlining the production of OPN isoforms. RESULTS: We discovered that OPNc was a most increased splicing isoform to a significant abundance following 5-FU treatment of colon cancer cells. OPNc as a secretory protein in the conditioned medium exerted a more potent effect to promote cell survival in 5-FU than other OPN isoforms. The kinetic response of nuclear calcium signals could be used to indicate an immediate effect of the conditioned medium containing OPNc and other isoforms. Methyl-CpG binding protein 2 (MeCP2) was identified to regulate the splicing of opn gene, where the phosphorylation of MeCP2 at S421 site, possibly by calmodulin dependent protein kinase II (CaMKII) was required. CONCLUSIONS: The results demonstrated that the production of OPNc was highly controlled under epigenetic regulations, where MeCP2 and the activation of nuclear calcium signaling were involved. It was also suggested that OPNc could transmit the stress signal of cells upon chemotherapy in TME and promoted the survival of adjacent colon cancer cells. |
format | Online Article Text |
id | pubmed-7491101 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-74911012020-09-16 Epigenetic regulation of osteopontin splicing isoform c defines its role as a microenvironmental factor to promote the survival of colon cancer cells from 5-FU treatment Chang, Siyuan Huang, Jing Niu, Huan Wang, Jing Si, Yang Bai, Zhigang Cheng, Shan Ding, Wei Cancer Cell Int Primary Research BACKGROUND: Drug resistance to 5-fluorouracil (5-FU) and recurrence after chemotherapy in colorectal cancer remain a challenge to be resolved for the improvement of patient outcomes. It is recognized that a variety of secretory proteins released from the tumor cells exposed to chemo-drugs into the tumor microenvironment (TME) contributed to the cell-to-cell communication, and altered the drug sensitivity. One of these important factors is osteopontin (OPN), which exists in several functional forms from alternative splicing and post-translational processing. In colon cancer cells, increased total OPN expression was observed during the progression of tumors, however, the exact role and regulation of the OPN splicing isoforms was not well understood. METHODS: We assayed precisely the abundance of major OPN splicing isoforms under 5-FU treatments in colon cancer cell lines with different sensitivities to 5-FU, and also evaluated the effects of the condition medium from OPN splicing isoforms overexpressed cells on cell functions. The methods of nuclear calcium reporter assays and ChIP (chromatin immunoprecipitation) assays were used to investigate the molecular mechanism underlining the production of OPN isoforms. RESULTS: We discovered that OPNc was a most increased splicing isoform to a significant abundance following 5-FU treatment of colon cancer cells. OPNc as a secretory protein in the conditioned medium exerted a more potent effect to promote cell survival in 5-FU than other OPN isoforms. The kinetic response of nuclear calcium signals could be used to indicate an immediate effect of the conditioned medium containing OPNc and other isoforms. Methyl-CpG binding protein 2 (MeCP2) was identified to regulate the splicing of opn gene, where the phosphorylation of MeCP2 at S421 site, possibly by calmodulin dependent protein kinase II (CaMKII) was required. CONCLUSIONS: The results demonstrated that the production of OPNc was highly controlled under epigenetic regulations, where MeCP2 and the activation of nuclear calcium signaling were involved. It was also suggested that OPNc could transmit the stress signal of cells upon chemotherapy in TME and promoted the survival of adjacent colon cancer cells. BioMed Central 2020-09-14 /pmc/articles/PMC7491101/ /pubmed/32944000 http://dx.doi.org/10.1186/s12935-020-01541-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Primary Research Chang, Siyuan Huang, Jing Niu, Huan Wang, Jing Si, Yang Bai, Zhigang Cheng, Shan Ding, Wei Epigenetic regulation of osteopontin splicing isoform c defines its role as a microenvironmental factor to promote the survival of colon cancer cells from 5-FU treatment |
title | Epigenetic regulation of osteopontin splicing isoform c defines its role as a microenvironmental factor to promote the survival of colon cancer cells from 5-FU treatment |
title_full | Epigenetic regulation of osteopontin splicing isoform c defines its role as a microenvironmental factor to promote the survival of colon cancer cells from 5-FU treatment |
title_fullStr | Epigenetic regulation of osteopontin splicing isoform c defines its role as a microenvironmental factor to promote the survival of colon cancer cells from 5-FU treatment |
title_full_unstemmed | Epigenetic regulation of osteopontin splicing isoform c defines its role as a microenvironmental factor to promote the survival of colon cancer cells from 5-FU treatment |
title_short | Epigenetic regulation of osteopontin splicing isoform c defines its role as a microenvironmental factor to promote the survival of colon cancer cells from 5-FU treatment |
title_sort | epigenetic regulation of osteopontin splicing isoform c defines its role as a microenvironmental factor to promote the survival of colon cancer cells from 5-fu treatment |
topic | Primary Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491101/ https://www.ncbi.nlm.nih.gov/pubmed/32944000 http://dx.doi.org/10.1186/s12935-020-01541-z |
work_keys_str_mv | AT changsiyuan epigeneticregulationofosteopontinsplicingisoformcdefinesitsroleasamicroenvironmentalfactortopromotethesurvivalofcoloncancercellsfrom5futreatment AT huangjing epigeneticregulationofosteopontinsplicingisoformcdefinesitsroleasamicroenvironmentalfactortopromotethesurvivalofcoloncancercellsfrom5futreatment AT niuhuan epigeneticregulationofosteopontinsplicingisoformcdefinesitsroleasamicroenvironmentalfactortopromotethesurvivalofcoloncancercellsfrom5futreatment AT wangjing epigeneticregulationofosteopontinsplicingisoformcdefinesitsroleasamicroenvironmentalfactortopromotethesurvivalofcoloncancercellsfrom5futreatment AT siyang epigeneticregulationofosteopontinsplicingisoformcdefinesitsroleasamicroenvironmentalfactortopromotethesurvivalofcoloncancercellsfrom5futreatment AT baizhigang epigeneticregulationofosteopontinsplicingisoformcdefinesitsroleasamicroenvironmentalfactortopromotethesurvivalofcoloncancercellsfrom5futreatment AT chengshan epigeneticregulationofosteopontinsplicingisoformcdefinesitsroleasamicroenvironmentalfactortopromotethesurvivalofcoloncancercellsfrom5futreatment AT dingwei epigeneticregulationofosteopontinsplicingisoformcdefinesitsroleasamicroenvironmentalfactortopromotethesurvivalofcoloncancercellsfrom5futreatment |